These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat. Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945 [TBL] [Abstract][Full Text] [Related]
6. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study. Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone secretagogues: discovery of small orally active molecules by peptidomimetic strategies. Ankersen M Prog Med Chem; 2002; 39():173-214. PubMed ID: 12536673 [No Abstract] [Full Text] [Related]
8. Changes in the somatotrophic axis in genetically identical dogs. Park J; Oh H; Kim M; Kim G; Park E; Jang G; Lee B Cell Reprogram; 2011 Oct; 13(5):451-7. PubMed ID: 21740269 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I. Wilson ME J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134 [TBL] [Abstract][Full Text] [Related]
10. Whither growth hormone in the catabolic state of critical illness? Van Den Berghe G Growth Horm IGF Res; 1999 Dec; 9(6):397-9. PubMed ID: 10629159 [No Abstract] [Full Text] [Related]
11. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion. Bowers CY; Granda-Ayala R Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505 [TBL] [Abstract][Full Text] [Related]
12. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats. Bercu BB; Yang SW; Masuda R; Hu CS; Walker RF Endocrinology; 1992 Dec; 131(6):2800-4. PubMed ID: 1446617 [TBL] [Abstract][Full Text] [Related]
13. Comparison of growth hormone-releasing factor and somatotropin: the somatotropic axis in lactating primiparous cows. Vanderkooi WK; Vandehaar MJ; Sharma BK; Binelli M; Tucker HA; Akers RM; Moseley WM J Dairy Sci; 1995 Oct; 78(10):2140-9. PubMed ID: 8598398 [TBL] [Abstract][Full Text] [Related]
14. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573 [TBL] [Abstract][Full Text] [Related]
15. Long-term somatotropic and galactopoietic effects of a (1-30) ethyl amide analog of growth hormone-releasing factor. Tucker HA; Terhune AL; Chapin LT; VandeHaar MJ; Sharma BK; Moseley WM J Dairy Sci; 1995 Jul; 78(7):1489-97. PubMed ID: 7593842 [TBL] [Abstract][Full Text] [Related]
16. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841 [TBL] [Abstract][Full Text] [Related]
17. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. Pihoker C; Badger TM; Reynolds GA; Bowers CY J Endocrinol; 1997 Oct; 155(1):79-86. PubMed ID: 9390009 [TBL] [Abstract][Full Text] [Related]
18. The growth hormone IGF-I axis in dilated cardiomyopathy. Jenkins RC; Ross RJ Clin Endocrinol (Oxf); 1999 Apr; 50(4):415-6. PubMed ID: 10468899 [No Abstract] [Full Text] [Related]
19. Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves. Roh SG; Matsunaga N; Hidaka S; Hidari H Endocr J; 1996 Jun; 43(3):291-8. PubMed ID: 8886623 [TBL] [Abstract][Full Text] [Related]
20. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. Mesotten D; Wouters PJ; Peeters RP; Hardman KV; Holly JM; Baxter RC; Van den Berghe G J Clin Endocrinol Metab; 2004 Jul; 89(7):3105-13. PubMed ID: 15240578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]